
|Articles|August 1, 2002
Government takes pro Maine prescription position
Although the Bush Administration, in the person of the Solicitor General, filed a brief with the U.S. Supreme Court suggesting that it refuse to hear an appeal from the Pharmaceutical Research and Manufacturers of America (PhRMA) on Maine's Rx prescription law, the court agreed to hear the case.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














